We are live on ! Find out more
EU

Emory University Portfolio holdings

AUM $267M
1-Year Est. Return 48.26%
This Fund
S&P 500
This Quarter Est. Return
+8.01%
1 Year Est. Return
+48.26%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$140M
AUM Growth
+$23.5M
Cap. Flow
+$20.7M
Cap. Flow %
14.77%
Top 10 Hldgs %
45.63%
Holding
53
New
9
Increased
27
Reduced
8
Closed
7

Top Buys

Rank Stock Value
1
BPMC
Blueprint Medicines
BPMC
+$2.77M
2
SAGE
Sage Therapeutics
SAGE
+$2.74M
3
DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
+$2.66M
4
XLRN
Acceleron Pharma
XLRN
+$2.65M
5
IFRX icon
InflaRx
IFRX
+$2.39M

Top Sells

Rank Stock Value
1
BCRX icon
BioCryst Pharmaceuticals
BCRX
+$1.88M
2
BKR icon
Baker Hughes
BKR
+$1.87M
3
AAAP
Advanced Accelerator Applications S.A.
AAAP
+$1.84M
4
TSRO
TESARO, Inc.
TSRO
+$1.69M
5
AVEO
AVEO Pharmaceuticals, Inc.
AVEO
+$1.68M

Sector Composition

Rank Sector Weight
1 Healthcare 53.45%
2 Financials 29.17%
3 Consumer Discretionary 3.76%
4 Technology 3.25%
5 Industrials 2.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
STX icon
26
Seagate
STX
$193B
$2.41M 1.72%
41,216
-5,938
-13% -$316K
DRNA
27
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$2.36M 1.68%
+246,411
New +$2.66M
DBVT
28
DBV Technologies
DBVT
$807M
$2.34M 1.67%
10,129
+1,937
+24% +$458K
LJPC
29
DELISTED
La Jolla Pharmaceutical Company
LJPC
$2.3M 1.64%
77,335
+25,703
+50% +$829K
BHVN
30
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$2.28M 1.63%
88,462
+14,084
+19% +$421K
CBRE icon
31
CBRE Group
CBRE
$40.8B
$2.21M 1.58%
46,888
+4,622
+11% +$211K
MSFT icon
32
Microsoft
MSFT
$2.84T
$2.15M 1.53%
23,505
+850
+4% +$77.7K
TFCF
33
DELISTED
Twenty-First Century Fox, Inc. Class B
TFCF
$2.08M 1.49%
57,218
-7,837
-12% -$286K
MS icon
34
Morgan Stanley
MS
$337B
$2.08M 1.48%
38,466
+555
+1% +$30.7K
GBT
35
DELISTED
Global Blood Therapeutics, Inc.
GBT
$2.01M 1.44%
41,610
-3,831
-8% -$214K
TRN icon
36
Trinity Industries
TRN
$2.97B
$1.99M 1.42%
84,494
+8,230
+11% +$203K
ESRX
37
DELISTED
Express Scripts Holding Company
ESRX
$1.95M 1.39%
+28,172
New +$2.15M
KKR icon
38
KKR & Co
KKR
$89.2B
$1.94M 1.38%
95,337
+1,393
+1% +$31K
AWI icon
39
Armstrong World Industries
AWI
$6.86B
$1.93M 1.38%
34,238
-1,721
-5% -$104K
WVE icon
40
Wave Life Sciences
WVE
$1.12B
$1.92M 1.37%
47,886
-15,127
-24% -$636K
ACAD icon
41
Acadia Pharmaceuticals
ACAD
$4.25B
$1.9M 1.36%
84,714
+16,956
+25% +$469K
BFH icon
42
Bread Financial
BFH
$4.21B
$1.84M 1.32%
10,853
+697
+7% +$136K
SMC
43
Summit Midstream
SMC
$421M
$1.23M 0.88%
5,837
– –
COCP icon
44
Cocrystal Pharma
COCP
$12.4M
$910K 0.65%
+12,743
New +$795K
AMZN icon
45
Amazon
AMZN
$2.5T
$229K 0.16%
+3,160
New +$226K
SPY icon
46
State Street SPDR S&P 500 ETF Trust
SPY
$778B
$229K 0.16%
872
-17
-2% -$4.64K
AAPL icon
47
Apple
AAPL
$4.89T
– –
-5,436
Closed -$230K
BCRX icon
48
BioCryst Pharmaceuticals
BCRX
$2.37B
– –
-383,768
Closed -$1.88M
BKR icon
49
Baker Hughes
BKR
$56.8B
– –
-58,965
Closed -$1.87M
AVEO
50
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
– –
-60,288
Closed -$1.68M
1
2
3

Similar funds

CFG
Cambridge Financial Group Columbus, Ohio $267M AUM 31.62% 1-Year Est. Return
PC
Packer & Co Cottesloe, Australia $267M AUM
ALC
Alexander Labrunerie & Co Columbia, Missouri $267M AUM 21.24% 1-Year Est. Return
TWM
TCFG Wealth Management Laguna Niguel, California $267M AUM 39.78% 1-Year Est. Return
IP
Indigo Partners Phoenix, Arizona $267M AUM 9% 1-Year Est. Return
SP
ShawSpring Partners Boston, Massachusetts $268M AUM 28.19% 1-Year Est. Return
EAIC
Empower Annuity Insurance Company Hartford, Connecticut $268M AUM 0.28% 1-Year Est. Return
STB
S&T Bank Indiana, Pennsylvania $268M AUM 39.92% 1-Year Est. Return

Emory University's Q1 2018 Portfolio in Review

As of Q1 2018, Emory University held 53 positions worth $140M, up 20% from $117M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Emory University deployed $20.7M of net new capital in Q1 2018, opening 9 new positions and adding to 27 existing holdings. Its largest new stake was Blueprint Medicines: 32,163 shares worth $2.95M.

By sector, the portfolio is most concentrated in Healthcare at 53% of assets, up from 45% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Wave Life Sciences, an estimated $636K trimmed.

  • Emory University's largest Q1 2018 buy was Blueprint Medicines: 32,163 shares worth $2.95M.
  • Emory University added most to Puma Biotechnology in Q1 2018, an estimated $1.65M increase.
  • Emory University's biggest Q1 2018 reduction was Wave Life Sciences, cutting an estimated $636K.
  • Emory University fully exited BioCryst Pharmaceuticals in Q1 2018, selling an estimated $1.88M.
  • Emory University's ten largest holdings make up 46% of its $140M portfolio in Q1 2018.
  • Emory University opened 9 new positions and closed 7 in Q1 2018.
  • Emory University's portfolio value rose 20% quarter-over-quarter to $140M.

Based on Emory University's 13F filing for Q1 2018, filed 14 May 2018.